These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 18812023
1. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. Manford F, Riffo-Vasquez Y, Spina D, Page CP, Hutt AJ, Moore V, Johansson F, Forbes B. J Pharm Pharmacol; 2008 Oct; 60(10):1305-10. PubMed ID: 18812023 [Abstract] [Full Text] [Related]
2. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein. Bonhomme-Faivre L, Benyamina A, Reynaud M, Farinotti R, Abbara C. Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception. Kalvass JC, Olson ER, Pollack GM. Drug Metab Dispos; 2007 Mar; 35(3):455-9. PubMed ID: 17178769 [Abstract] [Full Text] [Related]
5. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo. Chow EC, Durk MR, Cummins CL, Pang KS. J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739 [Abstract] [Full Text] [Related]
6. Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Lagas JS, Vlaming ML, van Tellingen O, Wagenaar E, Jansen RS, Rosing H, Beijnen JH, Schinkel AH. Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6125-32. PubMed ID: 17062689 [Abstract] [Full Text] [Related]
7. Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice. Chen C, Pollack GM. J Pharmacol Exp Ther; 1998 Nov 15; 287(2):545-52. PubMed ID: 9808679 [Abstract] [Full Text] [Related]
8. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. J Clin Invest; 1995 Oct 15; 96(4):1698-705. PubMed ID: 7560060 [Abstract] [Full Text] [Related]
10. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells. Washington CB, Wiltshire HR, Man M, Moy T, Harris SR, Worth E, Weigl P, Liang Z, Hall D, Marriott L, Blaschke TF. Drug Metab Dispos; 2000 Sep 15; 28(9):1058-62. PubMed ID: 10950849 [Abstract] [Full Text] [Related]
14. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse. Kawaguchi H, Matsui Y, Watanabe Y, Takakura Y. J Pharmacol Exp Ther; 2004 Jan 15; 308(1):91-6. PubMed ID: 14569074 [Abstract] [Full Text] [Related]
18. P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Drescher S, Glaeser H, Mürdter T, Hitzl M, Eichelbaum M, Fromm MF. Clin Pharmacol Ther; 2003 Mar 15; 73(3):223-31. PubMed ID: 12621387 [Abstract] [Full Text] [Related]
19. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Kwei GY, Alvaro RF, Chen Q, Jenkins HJ, Hop CE, Keohane CA, Ly VT, Strauss JR, Wang RW, Wang Z, Pippert TR, Umbenhauer DR. Drug Metab Dispos; 1999 May 15; 27(5):581-7. PubMed ID: 10220486 [Abstract] [Full Text] [Related]